STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL).
- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL).
- The early ICLs have evolved into the current generation of ICLs with a central port – the EVO ICL™ family of lenses.
- “We celebrate the 30th anniversary of our ICL technology with surgeons and patients,” said Tom Frinzi, President and CEO of STAAR Surgical.
- 1 Packer M. The Implantable Collamer Lens with a central port: review of the literature.